Tower Research Capital (TRC)’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $55.2K | Buy |
3,069
+1,600
| +109% | +$32.1K | ﹤0.01% | 2659 |
|
|
2025
Q4 | $34.4K | Buy |
1,469
+179
| +14% | +$3.88K | ﹤0.01% | 2704 |
|
|
2025
Q3 | $25.7K | Sell |
1,290
-5,601
| -81% | -$101K | ﹤0.01% | 3076 |
|
|
2025
Q2 | $94.4K | Buy |
6,891
+5,571
| +422% | +$53.5K | ﹤0.01% | 2428 |
|
|
2025
Q1 | $14.4K | Sell |
1,320
-265
| -17% | -$2.83K | ﹤0.01% | 3300 |
|
|
2024
Q4 | $16.9K | Sell |
1,585
-193
| -11% | -$2.31K | ﹤0.01% | 3337 |
|
|
2024
Q3 | $22.6K | Sell |
1,778
-1,590
| -47% | -$23.6K | ﹤0.01% | 3173 |
|
|
2024
Q2 | $56.5K | Buy |
3,368
+3,181
| +1,701% | +$45.2K | ﹤0.01% | 3006 |
|
|
2024
Q1 | $2.81K | Sell |
187
-1,504
| -89% | -$24.6K | ﹤0.01% | 4978 |
|
|
2023
Q4 | $25.4K | Sell |
1,691
-8,699
| -84% | -$113K | ﹤0.01% | 3512 |
|
|
2023
Q3 | $146K | Buy |
10,390
+9,686
| +1,376% | +$155K | ﹤0.01% | 1685 |
|
|
2023
Q2 | $7.29K | Sell |
704
-1,074
| -60% | -$11.8K | ﹤0.01% | 4592 |
|
|
2023
Q1 | $16K | Buy |
1,778
+37
| +2% | +$340 | ﹤0.01% | 3741 |
|
|
2022
Q4 | $15K | Sell |
1,741
-637
| -27% | -$6.03K | ﹤0.01% | 3455 |
|
|
2022
Q3 | $20K | Sell |
2,378
-135
| -5% | -$1.12K | ﹤0.01% | 3946 |
|
|
2022
Q2 | $21K | Buy |
2,513
+1,424
| +131% | +$9.78K | ﹤0.01% | 3764 |
|
|
2022
Q1 | $9K | Sell |
1,089
-1,116
| -51% | -$8.7K | ﹤0.01% | 4500 |
|
|
2021
Q4 | $21K | Buy |
2,205
+1,605
| +268% | +$22.6K | ﹤0.01% | 3625 |
|
|
2021
Q3 | $10K | Sell |
600
-2,694
| -82% | -$42.7K | ﹤0.01% | 4340 |
|
|
2021
Q2 | $50K | Sell |
3,294
-1,256
| -28% | -$22.7K | ﹤0.01% | 3028 |
|
|
2021
Q1 | $88K | Sell |
4,550
-1,138
| -20% | -$24.2K | ﹤0.01% | 2685 |
|
|
2020
Q4 | $103K | Sell |
5,688
-15,408
| -73% | -$323K | ﹤0.01% | 2322 |
|
|
2020
Q3 | $407K | Buy |
21,096
+18,263
| +645% | +$414K | ﹤0.01% | 1911 |
|
|
2020
Q2 | $74K | Buy |
+2,833
| New | +$69.2K | ﹤0.01% | 2731 |
|
|
2020
Q1 | – | Sell |
-596
| Closed | -$20K | – | 3929 |
|
|
2019
Q4 | $20K | Sell |
596
-1,404
| -70% | -$38.3K | ﹤0.01% | 1930 |
|
|
2019
Q3 | $47K | Buy |
2,000
+1,875
| +1,500% | +$61.3K | ﹤0.01% | 1841 |
|
|
2019
Q2 | $4K | Sell |
125
-2,854
| -96% | -$105K | ﹤0.01% | 3061 |
|
|
2019
Q1 | $110K | Buy |
2,979
+2,636
| +769% | +$111K | 0.01% | 1395 |
|
|
2018
Q4 | $15K | Sell |
343
-344
| -50% | -$15.5K | ﹤0.01% | 2176 |
|
|
2018
Q3 | $32K | Buy |
687
+549
| +398% | +$25.5K | ﹤0.01% | 2039 |
|
|
2018
Q2 | $7K | Sell |
138
-59
| -30% | -$3.43K | ﹤0.01% | 2969 |
|
|
2018
Q1 | $10K | Buy |
+197
| New | +$9.87K | ﹤0.01% | 2471 |
|
|
2017
Q4 | – | Sell |
-318
| Closed | -$10K | – | 4124 |
|
|
2017
Q3 | $10K | Buy |
318
+39
| +14% | +$861 | ﹤0.01% | 3080 |
|
|
2017
Q2 | $5K | Buy |
+279
| New | +$4.84K | ﹤0.01% | 2020 |
|
Other funds holding URGN
RI
KCM
JFG
PBA
ACA
